Items where Author is "Paolini, S"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 4.

Journal article

KAUFF, M., BENEDA, M., PAOLINI, S., BILEWICZ, M., KOTZUR, P., O'DONNELL, A.W., STEVENSON, C., WAGNER, U. and CHRIST, O., 2020. How do we get people into contact? Predictors of intergroup contact and drivers of contact seeking. Journal of Social Issues. ISSN 0022-4537

UY, G.L., ALDOSS, I., FOSTER, M.C., SAYRE, P.H., WIEDUWILT, M.J., ADVANI, A.S., GODWIN, J.E., ARELLANO, M.L., SWEET, K., EMADI, A., RAVANDI, F., ERBA, H.P., BYRNE, M., MICHAELIS, L.C., TOPP, M.S., VEY, N., CICERI, F., CARRABBA, M.G., PAOLINI, S., HULS, G., JONGEN-LAVRENCIC, M., WERMKE, M., CHEVALLIER, P., GYAN, E., RÉCHER, C., STIFF, P., PETTIT, K., LÖWENBERG, B., CHURCH, S., ANDERSON, E.K., VADAKEKOLATHU, J., SANTAGUIDA, M.T., RETTIG, M.P., MUTH, J., CURTIS, T., FEHR, E., GUO, K., ZHAO, J., BAKKACHA, O., JACOBS, K., TRAN, K., KAMINKER, P., KOSTOVA, M., BONVINI, E., WALTER, R.B., DAVIDSON-MONCADA, J.K., RUTELLA, S. and DIPERSIO, J.F., 2020. Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. Blood. ISSN 0006-4971

RAGAINI, S., WAGNER, S., MARCONI, G., PARISI, S., SARTOR, C., NANNI, J., CRISTIANO, G., TALAMI, A., OLIVI, M., OCADLIKOVA, D., CICIARELLO, M., CORRADI, G., OTTAVIANI, E., PAPAYANNIDIS, C., PAOLINI, S., VADAKEKOLATHU NARAYANAN, J., CAVO, M., RUTELLA, S. and CURTI, A., 2019. An IDO1-related 3-gene signature predicts overall survival in intermediate-risk acute myeloid leukemia. Blood, 134 (Supp1): 5193. ISSN 0006-4971

UY, G.L., RETTIG, M.P., VEY, N., GODWIN, J., FOSTER, M.C., RIZZIERI, D.A., ARELLANO, M.L., TOPP, M.S., HULS, G., JONGEN-LAVRENCIC, M., MARTINELLI, G., PAOLINI, S., CICERI, F., CARRABBA, M.G., SWEET, K.L., RAVANDI, F., CHURCH, S.E., VADAKEKOLATHU, J., RUTELLA, S., SUN, J., YANG, K., BAUGHMAN, J., CURTIS, T., TIMMENY, E., CALI, K., TRAN, K., MUTH, J., LA MOTTE-MOHS, R., POIROT, C., PALLIS, A., CESANO, A., BONVINI, E., WIGGINGTON, J., LOWENBERG, B., DAVIDSON-MONCADA, J.K. and DIPERSIO, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971

This list was generated on Sun Jan 24 03:59:29 2021 UTC.